Logo

The Yankees hoped a few days of rest could help DJ LeMahieu manage his lingering right toe inflammation.

Now he’ll have at least 10, if not more.

The team placed LeMahieu on the 10-day injured list Thursday, adding to their growing list of injury woes, though there’s no guarantee that this extended period of rest and treatment will solve the infielder’s nagging toe issue.

Asked if any part of him thought he may not get LeMahieu back this season, manager Aaron Boone didn’t rule it out.

“I’m concerned about it, obviously, because DJ’s been dealing with this now for a few weeks where it’s clearly compromised him,” Boone said before the Yankees wrapped up a series with the Twins. “So yeah, there’s that concern. But there’s also hope with that. There hopefully are things that, on top of this timeout, this rest, hopefully the things they get to are things that free it up to where he can get back to being really productive for us.”

LeMahieu previously sat out three straight games in August to try to address the toe issue. But after taking the rest, receiving treatment and getting orthotics, the 34-year-old returned to action hoping he would be able to manage it the rest of the season.


  DJ LeMahieu had been struggling at the plate due to a nagging toe injury. Corey Sipkin DJ LeMahieu had been struggling at the plate due to a nagging toe injury. Corey Sipkin

But the injury clearly continued to affect LeMahieu at the plate. Over his last 20 games, he was batting 10-for-78 (.128) with no extra-base hits and a .307 OPS, far from the player who has often served as a key cog atop the Yankees’ lineup.

Boone had previously said that the injury was not one that would necessarily get better with time off, but after LeMahieu tried to play through it with poor results, the Yankees changed course.

“Just because it hasn’t worked well enough,” Boone said. “Hopefully feeling like this timeout, they’ll continue to confer on courses of action about what to take to where we can get him to a point to where he’s the player we all expect. Playing through it, we haven’t been able to get there. I know they’re talking about a lot of different things they can possibly do. We’ll see how it works.”

Boone mentioned the possibility of the infielder getting another injection, after LeMahieu received a cortisone shot during the All-Star break that temporarily addressed the problem.

With LeMahieu not having played since Sunday, the Yankees backdated his IL stint to Monday, which would make him eligible to be activated on Sept. 15 at the earliest. But it remains to be seen whether he will actually be an option by then.

“I don’t think it’s gotten any worse than where it really reared its head when we were in Boston … before he had those first few off days,” Boone said. “Because it had gotten to a point to where he just couldn’t bear it. So he hasn’t been at that point any time since, it’s just been sore. It’s just prevented him from really getting off his swing.

“I think it’s really that ripping on the back side. It’s not a pain tolerance thing necessarily, because especially DJ, [he] is as tough as they come. He can deal with the pain. But it’s just something that prevents him from really torquing on that back side, which compromises him enough to where he’s not able to really drive the ball like he’s capable of.”

Last year, the Yankees lost LeMahieu to a sports hernia just before the final weekend of the regular season.

This year, LeMahieu’s IL stint comes at a time when the Yankees are already without Anthony Rizzo (headaches following epidural injection), Andrew Benintendi (broken hook of hamate bone), Matt Carpenter (broken foot) and Harrison Bader (plantar fasciitis), in addition to a slew of pitchers.

Without LeMahieu, Rizzo and Carpenter, the Yankees’ only options at first base are Marwin Gonzalez and Ronald Guzman.

Miguel Andujar, who served as the 29th man for Wednesday’s doubleheader, was called back up from Triple-A to take LeMahieu’s roster spot.

Comments
anonymous profile image
Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy